Matches in SemOpenAlex for { <https://semopenalex.org/work/W2970060324> ?p ?o ?g. }
- W2970060324 endingPage "6271" @default.
- W2970060324 startingPage "6258" @default.
- W2970060324 abstract "Abstract Background Identifying optimal chemotherapy (CT) utilization rates can drive improvements in quality of care. We report a benchmarking approach to estimate the optimal rate of perioperative CT for muscle‐invasive bladder cancer (MIBC). Methods The Ontario Cancer Registry and linked treated records were used to identify neoadjuvant and adjuvant CT rates among patients with MIBC during 2004‐2013. Monte Carlo simulation was used to estimate the proportion of observed rate variation that could be due to chance alone. The criterion‐based benchmarking approach was used to explore whether social and health‐system factors were associated with CT rates. We also used the “pared‐mean” approach to identify a benchmark population of hospitals with the highest treatment rates. Hospital CT rates were adjusted for case mix and simulated using a multi‐level multivariable model and a parametric bootstrapping approach. Results The study population included 2581 patients; perioperative CT was delivered to 31% (798/2581). Multivariate analysis showed that treatment was strongly associated with patient socioeconomic status and hospital teaching status. The benchmark rate was 36%. Unadjusted CT rates were significantly different across hospitals (range 0%‐52%, P < .001). The unadjusted benchmark perioperative CT rate was 45% (95% CI 40%‐50%); utilization rate in nonbenchmark hospitals was 28% (95% CI 26%‐30%). When using simulated CT rates adjusted for case mix, the benchmark CT rate was 41% (95% CI 35%‐47%) and the nonbenchmark hospital CT rate was 30% (95% CI 28%‐32%). The simulation analysis suggested that the observed component of variation (38%) was outside the 95% CI (22%‐28%) of what could be expected due to chance alone. Conclusions There is significant systematic variation in perioperative CT rates for MIBC across hospitals in routine practice. The benchmark perioperative CT rate for MIBC is 36%‐41%." @default.
- W2970060324 created "2019-09-05" @default.
- W2970060324 creator A5039020643 @default.
- W2970060324 creator A5049472424 @default.
- W2970060324 creator A5061933475 @default.
- W2970060324 creator A5073771690 @default.
- W2970060324 creator A5082918271 @default.
- W2970060324 creator A5088442918 @default.
- W2970060324 creator A5089899558 @default.
- W2970060324 date "2019-08-31" @default.
- W2970060324 modified "2023-09-27" @default.
- W2970060324 title "Estimating the optimal perioperative chemotherapy utilization rate for muscle‐invasive bladder cancer" @default.
- W2970060324 cites W1501997055 @default.
- W2970060324 cites W1936274243 @default.
- W2970060324 cites W1974800834 @default.
- W2970060324 cites W1975918912 @default.
- W2970060324 cites W1989898892 @default.
- W2970060324 cites W2029822285 @default.
- W2970060324 cites W2049756688 @default.
- W2970060324 cites W2103561213 @default.
- W2970060324 cites W2128042367 @default.
- W2970060324 cites W2129168200 @default.
- W2970060324 cites W2131952300 @default.
- W2970060324 cites W2133862671 @default.
- W2970060324 cites W2151278059 @default.
- W2970060324 cites W2157480659 @default.
- W2970060324 cites W2166453367 @default.
- W2970060324 cites W2195378667 @default.
- W2970060324 cites W2199618292 @default.
- W2970060324 cites W2773177438 @default.
- W2970060324 cites W2952699285 @default.
- W2970060324 cites W3021615066 @default.
- W2970060324 cites W4251062817 @default.
- W2970060324 doi "https://doi.org/10.1002/cam4.2449" @default.
- W2970060324 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6797575" @default.
- W2970060324 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31472011" @default.
- W2970060324 hasPublicationYear "2019" @default.
- W2970060324 type Work @default.
- W2970060324 sameAs 2970060324 @default.
- W2970060324 citedByCount "5" @default.
- W2970060324 countsByYear W29700603242020 @default.
- W2970060324 countsByYear W29700603242021 @default.
- W2970060324 countsByYear W29700603242022 @default.
- W2970060324 countsByYear W29700603242023 @default.
- W2970060324 crossrefType "journal-article" @default.
- W2970060324 hasAuthorship W2970060324A5039020643 @default.
- W2970060324 hasAuthorship W2970060324A5049472424 @default.
- W2970060324 hasAuthorship W2970060324A5061933475 @default.
- W2970060324 hasAuthorship W2970060324A5073771690 @default.
- W2970060324 hasAuthorship W2970060324A5082918271 @default.
- W2970060324 hasAuthorship W2970060324A5088442918 @default.
- W2970060324 hasAuthorship W2970060324A5089899558 @default.
- W2970060324 hasBestOaLocation W29700603241 @default.
- W2970060324 hasConcept C121608353 @default.
- W2970060324 hasConcept C126322002 @default.
- W2970060324 hasConcept C141071460 @default.
- W2970060324 hasConcept C144133560 @default.
- W2970060324 hasConcept C159110408 @default.
- W2970060324 hasConcept C162853370 @default.
- W2970060324 hasConcept C194828623 @default.
- W2970060324 hasConcept C2778527826 @default.
- W2970060324 hasConcept C2780352672 @default.
- W2970060324 hasConcept C2908647359 @default.
- W2970060324 hasConcept C31174226 @default.
- W2970060324 hasConcept C38180746 @default.
- W2970060324 hasConcept C71924100 @default.
- W2970060324 hasConcept C86251818 @default.
- W2970060324 hasConcept C88579808 @default.
- W2970060324 hasConcept C99454951 @default.
- W2970060324 hasConceptScore W2970060324C121608353 @default.
- W2970060324 hasConceptScore W2970060324C126322002 @default.
- W2970060324 hasConceptScore W2970060324C141071460 @default.
- W2970060324 hasConceptScore W2970060324C144133560 @default.
- W2970060324 hasConceptScore W2970060324C159110408 @default.
- W2970060324 hasConceptScore W2970060324C162853370 @default.
- W2970060324 hasConceptScore W2970060324C194828623 @default.
- W2970060324 hasConceptScore W2970060324C2778527826 @default.
- W2970060324 hasConceptScore W2970060324C2780352672 @default.
- W2970060324 hasConceptScore W2970060324C2908647359 @default.
- W2970060324 hasConceptScore W2970060324C31174226 @default.
- W2970060324 hasConceptScore W2970060324C38180746 @default.
- W2970060324 hasConceptScore W2970060324C71924100 @default.
- W2970060324 hasConceptScore W2970060324C86251818 @default.
- W2970060324 hasConceptScore W2970060324C88579808 @default.
- W2970060324 hasConceptScore W2970060324C99454951 @default.
- W2970060324 hasFunder F4320319952 @default.
- W2970060324 hasFunder F4320334576 @default.
- W2970060324 hasIssue "14" @default.
- W2970060324 hasLocation W29700603241 @default.
- W2970060324 hasLocation W29700603242 @default.
- W2970060324 hasLocation W29700603243 @default.
- W2970060324 hasLocation W29700603244 @default.
- W2970060324 hasOpenAccess W2970060324 @default.
- W2970060324 hasPrimaryLocation W29700603241 @default.
- W2970060324 hasRelatedWork W2352247659 @default.
- W2970060324 hasRelatedWork W2354785620 @default.
- W2970060324 hasRelatedWork W2375359181 @default.
- W2970060324 hasRelatedWork W2392422383 @default.